This application claims priority to U.S. provisional application No. 61/925,287 filed on Jan. 9, 2014, of which is incorporated herein by reference in its entireties.
The present invention relates generally to the field of vascular access ports. More specifically, the present invention relates to multi-reservoir port and infusion needle systems that support high-flow applications such as hemodialysis and apheresis.
Multi-lumen catheters are commonly used for extracorporeal procedures in which blood is removed from the vascular system through an aspiration lumen, treated and returned to circulation through an infusion lumen. Apheresis is one example an extracorporeal procedure in which a patient's blood is removed from the vascular system, passed through a machine that removes specific blood components (e.g., plasma, red blood cells, white blood cells and/or platelets etc.) and then returned to circulation. Apheresis procedures generally last from one to four hours, although these times may vary depending on the procedure being performed, the medical condition being treated, the size of the patient and the type of machine being used. The number of treatments also varies based on the procedure being performed. Some procedures, such as red blood cell exchange, are only performed once. In other situations the patient is re-evaluated after two or three procedures to determine if they are responding to the treatment. Certain diseases require a pre-set treatment schedule that may include, for example, five procedures over the course of two weeks. Other procedures require the patient to follow a routine schedule of treatment that may vary from multiple times per week to once per month. Examples of apheresis procedures that require frequent treatments include plasma exchange (e.g., the removal of harmful substances from the blood plasma and subsequent replacement with saline, normal serum albumin or fresh frozen plasma); low density lipoprotein (LDL) apheresis (e.g., to treat familial hypercholesterolemia); photopheresis (e.g., to treat graft-versus-host disease; cutaneous T-cell lymphoma; or heart transplant rejection); allo- and autoantibody removal (e.g., to treat autoimmune disease; hemophilia; or transplant rejection); leukocytapheresis (e.g., to remove malignant white blood cells in leukemia) and thrombocytapheresis (e.g., to treat essential thrombocythemia; or polycythemia vera). Hemodialysis is another example of an extracorporeal procedure in which waste products, such as creatinine, urea, potassium, phosphate and/or free water, are removed from the blood of a patient whose kidneys are in a state of renal failure. In general, hemodialysis treatments are required once a patient has lost 85 to 90 percent of their kidney function. A typical treatment schedule requires performing hemodialysis 3 times a week, although patients who have retained substantial residual kidney function might only require sessions twice-a-week. Larger patients, or patients who have difficulties with fluid overload, may require four hemodialysis sessions per week are often prescribed for larger patients. Short daily home hemodialysis treatments may be performed as frequently as five to seven times per week. While both procedures require the continued re-circulation of blood through an external apparatus, the flow rates required for hemodialysis generally exceed those required for apheresis. For example, hemodialysis typically requires flow rates in the range 300-400 ml/min, but can sometimes exceed 800 ml/min. By contrast, the flow rates required for apheresis procedures can range from 30-60 ml/min (e.g., red blood cell exchange) to 150 ml/min (e.g., plasma exchange).
Medical professionals often prefer the use of implantable ports over peripherally inserted central catheters (i.e., PICCs) for procedures such as apheresis and hemodialysis that require repeated and/or prolonged access to the vascular system. One advantage of implantable ports is that they are completely indwelling, and therefore minimize the risk of infection, especially in patients requiring chronic care. Implantable ports are also more amenable to patients with active lifestyles since their relatively low profile allows them to be easily hidden from view. Ports are typically implanted in the patient's chest and connected to a catheter having a distal tip positioned at the point of treatment. For example, for many medical procedures the catheter tip is positioned at the junction of the superior vena cava and the right atrium. Implantable ports generally include a reservoir (i.e., chamber) in fluid communication with a catheter. The reservoir is typically covered by a needle-penetrable and self-sealing elastomeric septum. The self-sealing septum allows the reservoir to be accessed by puncturing both the patient's skin and the septum with a needle, for example, to infuse and/or aspirate fluid to and from the distal tip of the catheter.
For medical procedures that require multi-lumen access to the vascular system it is common for two ports to be implanted within the patient. While a variety of arrangements are possible, it is most common for one port to be implanted within the patient's left arm and the other port implanted within the right arm. In addition to the increased cost associated with implanting two ports, the separate invasive procedures dramatically increases patient discomfort and the likelihood of negative outcomes such as infection. These problems may be avoided by implanting a multi-reservoir port, which allows the administration of fluid through one reservoir and aspiration of fluid through a separate reservoir. While multi-reservoir ports are more cost-efficient, minimize patient discomfort and decrease patient exposure, they do have drawbacks.
Since fluid flows through a conventional multi-reservoir port (including the catheter) as a continuous stream, it is important that pressure on the aspiration side remains equal (i.e., balanced) to the pressure on the infusion side. With the power source for fluid flow provided by the apheresis or hemodialysis machine, fluid is essentially pulled through the aspiration side under negative pressure and pushed through the infusion side under positive pressure. This requires fluid on the aspiration side to travel a greater distance to reach the power source than fluid on the infusion side, resulting in the formation of high intraluminal negative pressures. These negative pressures force the lumen of the aspiration catheter to collapse or constrict, thereby restricting the flow of fluid throughout the entire system. To avoid harming the patient, automated apheresis and hemodialysis machines are designed to set-off pressure alarms when high intraluminal pressure is detected.
To maintain the proper pressure balance within multi-reservoir port systems, medical professionals typically access the aspiration reservoir of conventional multi-reservoir port systems with a 16 gauge needle. The large inner diameter of the 16 gauge needle is preferred over smaller 18 or 19 gauge needles because they allow fluid to flow into the aspiration reservoir under minimal pressure such that pressure alarms are not set-off. Due to its large inner diameter, a trocar is inserted into the lumen of the 16 gauge needle to prevent coring of the elastomeric septum covering the aspiration reservoir. Unfortunately, the size and shape of standard 16 gauge trocar needles creates large puncture sites within the elastomeric septum. Repeated overlapping punctures by the 16 gauge trocar eventually result in the formation of leakage sites within the septum, ultimately rendering the port unsuitable for safe and reliable use.
As evidenced by the competing interests of maintaining septum integrity and avoiding high intraluminal negative pressure, there is a continuing need for multi-reservoir port and non-coring needle systems that support high-flow applications with minimal impact on the puncture life of the elastomeric septum.
The present invention relates generally to multi-reservoir port, catheter and non-coring needle systems that support high-flow applications such as hemodialysis and apheresis. In one aspect, the present invention relates to improved port, catheter and needle systems that provide, both alone and in combination, optimal flow rates and septum puncture life with minimal intraluminal pressure.
In one embodiment, the present invention relates to a high flow multi-reservoir port assembly, comprising a vascular access port that includes a housing defining first (i.e., aspiration) and second (i.e., infusion) reservoirs. A first septum is mounted within the housing to seal the first reservoir, and a second septum is mounted within the housing to seal the second reservoir. The first and second septa (plural) are configured to be penetrable by a needle, and self-sealing after the needle is withdrawn. An inlet stem with an inlet lumen is in fluid communication with the first reservoir, and an outlet stem with an outlet lumen is in fluid communication with the second reservoir. The inlet and outlet stems are in fluid communication with a dual-lumen catheter that includes a proximal end, a distal end and first and second lumens extending therebetween. The catheter includes a smooth outer surface having a substantially circular outer diameter. The inlet stem is dimensioned to receive the first lumen at the proximal end of the catheter, and the outlet stem is dimensioned to receive the second lumen at the proximal end of the catheter. The first and second septa comprise an elastomeric material, including, for example, a multi-durometer material. The elastomeric material is self-sealing. The multi-durometer elastomeric material may comprise a first layer with a first durometer and a second layer with a second durometer. For example, the durometer of the material of the first layer may be less than the durometer of the material of the second layer. The first layer may be disposed above (i.e., on top of) the second layer. Alternatively, the first layer may surround the second layer. The first layer may also be disposed both above and below the second layer, such that the second layer is effectively sandwiched between two first layers. The first and second layers may include a variety of thicknesses. For example, the thickness of the second layer may be greater than the thickness of the first layer. Alternatively, the thickness of the first and second layers may be substantially the same. The first lumen of the catheter comprises a first inner diameter, and the second lumen of the catheter comprises a second inner diameter, wherein the second inner diameter is smaller than the first inner diameter. The first and second lumens of the catheter may include a variety of shapes. For example, the first inner diameter may define a substantially oval shape, while the second inner diameter may define a substantially concave shape. The first and second lumens of the catheter also define respective first and second openings at the distal end of the catheter. The openings do not necessarily terminate at the same location along the length of the catheter. For example, the first opening may be located proximal to the second opening. That is, the second opening may be located at or near the distal tip of the catheter, while the first opening is located at a position closer to the port. The first opening may also be substantially perpendicular to the second opening.
In another aspect, the present invention relates to a needle assembly, comprising at least one infusion needle and at least two aspiration needles. The at least one infusion needle is configured to penetrate the second septum of the second reservoir, while the at least two aspiration needles are configured to penetrate the first septum of the first reservoir (described above). The aspiration and infusion needles are, therefore, in fluid communication with the aspiration and infusion reservoirs, respectively. The at least one infusion needle and the at least two aspiration needles may include non-coring (i.e., Huber) needles. Needles of any size (i.e., gauge) may be used, for example, both the infusion and aspiration needles may be at least 19 gauge. To establish optimal fluid flow, the at least two aspiration needles may include openings that face in substantially opposite directions. Alternatively, the openings of the at least two aspiration needles may be configured such that they both face the inlet port of the aspiration reservoir. The at least two needles may be attached to each other, at for example, a y-site. The infusion needle may also include an opening configured to face the outlet port of the infusion reservoir. The at least two aspiration needles and at least one infusion needle allow the aspiration and infusion reservoirs to be in fluid communication with a blood circulation apparatus, such as an apheresis or hemodialysis machine.
In another embodiment, the present invention contemplates kits for the practice of the methods of this invention. The kits may include one or more containers containing a multi-reservoir implantable port, an aspiration needle assembly, an infusion needle assembly and catheter.
As used herein, “coring” refers to any portion of the septum that is forced into the shaft of a needle as the needle tip advances through the septum body. Septum coring produces small, detached particles that may become trapped in the cardiovascular system of the patient. In addition to potentially harming the patient, these particles can obstruct fluid flow through the needle assemblies and/or outlet stem of the multi-reservoir port. While a septum is capable of withstanding a certain number of coring events, continued coring creates a series of small passageways that extend through the body of the septum and eventually lead to various forms of septum failure. To at least partially address this problem, non-coring (e.g., Huber) needles are preferably used in conjunction with aspiration and infusion assemblies for accessing port reservoirs. Unlike traditional hypodermic needles, non-coring Huber needles pierce the septum in a knife-like fashion, thereby facilitating the resealing of the septum so that the aforementioned problems are largely averted.
As used herein, “trocar” refers to a surgical instrument having a sharpened point used to puncture a percutaneous surface for a variety of minimally invasive medical applications. In one embodiment, the body of the trocar includes a hollow tube through which a variety of medical instruments can be inserted into a patient's body. Alternatively, the body of the trocar can include a solid shaft, or sealed tube, dimensioned to fit within and reversibly occlude the lumen of a needle. The pointed tip of the trocar extends beyond, or is substantially flush with, the pointed end of the needle. Once the target surface (e.g., the skin, septum etc.) has been penetrated, the trocar is removed such that the lumen of the needle remains in fluid contact with the selected reservoir, chamber or body site.
As used herein, “durometer” refers to the measurement of a material's resistance to permanent indentation (i.e., hardness), and is typically used in reference to polymers, elastomers rubbers and the like. A material's durometer value can be determined by measuring the depth of an indentation in the material created by a given force on a standardized pressure foot. The depth of the indentation within the material is dependent on a variety of factors, including the density of the material, its viscoelastic properties, the shape of the pressure foot and the duration of the test.
As used herein, a “staggered tip” refers to a dual-lumen catheter that prevents fluid recirculation by positioning the entry site of the aspiration lumen away from the exit site of the infusion lumen (located at or near the catheter tip). Staggered-tip catheter designs are known in the art, including for example U.S. Pat. Nos. 8,317,773 and D603,044, herein incorporated by reference. The staggered tip design ensures that treated blood exiting the infusion lumen is carried away from the catheter tip as it re-enters circulation.
Other aspects, features, and advantages of the present invention are outlined in the detailed description, drawings, and claims.
Non-limiting embodiments of the present disclosure will be described by way of example with reference to the accompanying figures, which are schematic and not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the disclosure shown where illustration is not necessary to allow those of ordinary skill in the art to understand the disclosure.
The present invention may be further understood with reference to the following description and the appended drawings, wherein like elements are referred to with the same reference numerals. The systems and methods of the present invention relate to multi-reservoir port, catheter and needle systems that support high-flow applications such as hemodialysis and apheresis. However, those skilled in the art will understand that the present invention is equally pertinent to a wide range of applications that benefit from the implantation of multi-reservoir ports with self-sealing septa, and which are accessible by a corresponding non-coring needle assembly.
As described herein, the present invention improves upon various components of conventional implantable port, needle-assembly and catheter designs to provide a system capable of maintaining balanced intraluminal fluid pressure required for high flow applications, without a corresponding decrease in septum puncture life. These advantages include 1) needle designs and configurations that provide optimal fluid flow and minimize damage to the septum, 2) dual-durometer septum designs and configurations that optimize self-sealing and minimize coring and 3) dual-lumen catheter designs and configurations that facilitate low pressure fluid flow within the aspiration lumen and prevent lumen constriction/collapsing. The cumulative effect that results from combining any, or all, of these improvements into a single system exceeds the improvements realized by an individually improvement alone. These improvements provide direct and immediate benefits to both the patient and medical professional. For example, the multi-reservoir ports decrease patient discomfort during implantation by requiring only a single invasive procedure, and are easier to conceal than separate single-reservoir ports implanted at different locations within the body. Patient discomfort is also decreased during treatment by limiting needle punctures through the skin to a single access site. Additionally, the ability to withstand a high number of needle punctures without septum failure allows expensive and invasive port replacement procedures to be postponed, or avoided altogether. This represents a significant savings in terms of medical costs, as well patient discomfort and risk exposure to.
Multi-reservoir ports typically used in situations that require multi-lumen access to the vascular system. Examples of multi-reservoir ports, including the manner of fabrication and method of use are described in U.S. Patent Publication Nos. 20130150811 and 20090118683, each of which is assigned to Angiodynamics, Inc. of Latham, N.Y., and are fully incorporated herein by reference. Referring to
Referring to
Medical procedures such as apheresis or hemodialysis require the septa covering the aspiration and infusion reservoirs to be frequently and repetitively punctured with a needle. The cumulative damage resulting from these needle penetrations gradually degrades the elastomeric septum until it is eventually unable to re-seal itself. The number of punctures that a septum can withstand depends on the size of the port, the type of elastomeric material, the durometer of the elastomeric material and the size of needle(s).
Referring to
Although two non-coring 19 gauge needles provide less cross-sectional area than a single 16 gauge needle, the fluid pressure they achieve is sufficiently similar to that of 16 gauge needle to prevent the aspiration lumen from constricting and/or collapsing upon itself. The ability of two 19 gauge needles to achieve fluid pressures that maintain aspiration lumen integrity similar to one 16 gauge needle while providing a higher clinically acceptable number of septum punctures represents a significant clinical advantage for high flow procedures.
In one embodiment, fluid flow may be further optimized by adjusting the orientation of each needle opening (i.e., bevel) in the needle assembly depicted in
In yet another embodiment, flow rates through the aspiration and/or infusion needle assemblies can be further optimized by using needle shaft designs that reduce the pressure required to meet the desired flow rates. For example, the length of the small inner diameter of a needle of standard length and shape (
Since ports are fully implanted within the body, their service life is limited in large part by the durability (i.e., puncture life) of the septum. Septum puncture life, and therefore the life of the multi-reservoir port, can be optimized by careful selection of the septum material and the dimensions of the septum within the port assembly. Examples of needle-penetrable and self-sealable materials include, but are not limited to, silicone and related elastomeric materials. Regardless of the material used, after a threshold number of needle punctures the septum becomes damaged and is no longer able to re-seal itself. Once the integrity of the septum is compromised to the point that it can no longer prevent fluid leakage, either into or out of the port reservoir, it is necessary to replace the entire port assembly, and possibly the attached catheter as well. Generally, the ability of a septum to self-seal and resist coring is directly related to the durometer of the material it is constructed from. While low durometer materials tends to reduce coring, they are not as effective at self-sealing after withdrawal of the needle. Similarly, high durometer materials promote better self-sealing after needle withdrawal, but tend to core relatively easily. Due to these competing requirements, the septum of conventional implantable ports generally include elastomeric materials having a durometer that resists coring and is capable of self-sealing, but is not optimal for either criteria.
In another embodiment, the present invention provides a septum comprising a dual-durometer elastomeric material that includes one layer configured to minimize coring (i.e., a low durometer material) and a second layer configured for optimal self-sealing (i.e., a high durometer material). Optimizing the self-sealing and non-coring capabilities of the septum with a dual-durometer materials enhances flow rates throughout the system by allowing repeated penetration with large gauge needles. For example, as shown in
In another embodiment, the dual-durometer characteristics of the multi-layer septum of
In one embodiment, flow rates may be further optimized by providing a dual-lumen catheter that includes an aspiration lumen that is over-sized as compared to the infusion lumen. The larger diameter of the aspiration lumen ensures that fluid flows from the proximal end of the catheter to the aspiration reservoir under minimal pressure. An additional benefit of using a dual-lumen that includes differently shaped aspiration and infusion lumens is that it becomes practically impossible to connect the distal end of the catheter to the incorrect inlet or outlet stem. As illustrated in
All of the systems, assemblies and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the present invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations can be applied to the systems, assemblies and/or methods described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
While embodiments of the invention have been illustrated and described, it is not intended that these embodiments illustrate and describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
1653819 | Northcott et al. | Dec 1927 | A |
3094124 | Birtwell | Jun 1963 | A |
3392183 | Windemuth | Jul 1968 | A |
3427366 | Verdol et al. | Feb 1969 | A |
3438375 | Ericson | Apr 1969 | A |
3872058 | Gresham | Mar 1975 | A |
3971376 | Wichterle | Jul 1976 | A |
3978157 | Bottenbruch et al. | Aug 1976 | A |
4016886 | Doss et al. | Apr 1977 | A |
4054139 | Crossley | Oct 1977 | A |
4142525 | Binard et al. | Mar 1979 | A |
4226246 | Fragnet | Oct 1980 | A |
4245635 | Kontos | Jan 1981 | A |
4248224 | Jones | Feb 1981 | A |
4262672 | Kief | Apr 1981 | A |
4309994 | Grunwald | Jan 1982 | A |
4312907 | Hiraoka et al. | Jan 1982 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4405305 | Stephen et al. | Sep 1983 | A |
4407943 | Cole et al. | Oct 1983 | A |
4423740 | Castle et al. | Jan 1984 | A |
4425119 | Berglund | Jan 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4469483 | Becker et al. | Sep 1984 | A |
4483688 | Akiyama | Nov 1984 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4569673 | Tesi | Feb 1986 | A |
4571749 | Fischell | Feb 1986 | A |
4584362 | Leckart et al. | Apr 1986 | A |
4587954 | Haber | May 1986 | A |
4592920 | Murtfeldt | Jun 1986 | A |
4603152 | Laurin et al. | Jul 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4661530 | Gogolewski et al. | Apr 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4742090 | Hunter et al. | May 1988 | A |
4767410 | Moden et al. | Aug 1988 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4788083 | Dammann et al. | Nov 1988 | A |
4792354 | Matsuo et al. | Dec 1988 | A |
4804359 | Grunwald et al. | Feb 1989 | A |
4808156 | Dean | Feb 1989 | A |
4810963 | Blake-Coleman et al. | Mar 1989 | A |
4822341 | Colone | Apr 1989 | A |
4838269 | Robinson et al. | Jun 1989 | A |
4838873 | Landskron et al. | Jun 1989 | A |
4857053 | Dalton | Aug 1989 | A |
4861830 | Ward, Jr. | Aug 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4902503 | Umemura et al. | Feb 1990 | A |
4907601 | Frick | Mar 1990 | A |
4929236 | Sampson | May 1990 | A |
4944726 | Hilal et al. | Jul 1990 | A |
4946793 | Marshall, III | Aug 1990 | A |
4954130 | Edwards | Sep 1990 | A |
4955861 | Enegren et al. | Sep 1990 | A |
4966586 | Vaillancourt | Oct 1990 | A |
4983162 | Metais et al. | Jan 1991 | A |
4994503 | Harris et al. | Feb 1991 | A |
4999210 | Solomon et al. | Mar 1991 | A |
5013304 | Russell et al. | May 1991 | A |
5019034 | Weaver et al. | May 1991 | A |
5019096 | Fox, Jr. et al. | May 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5052391 | Silberstone et al. | Oct 1991 | A |
5053013 | Ensminger et al. | Oct 1991 | A |
5053023 | Martin | Oct 1991 | A |
5053423 | Liu | Oct 1991 | A |
5058605 | Slovak | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5064871 | Sciangola | Nov 1991 | A |
5069206 | Crosbie | Dec 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5092849 | Sampson | Mar 1992 | A |
5098843 | Calvin | Mar 1992 | A |
5125893 | Dryden | Jun 1992 | A |
5129887 | Euteneuer et al. | Jul 1992 | A |
5129891 | Young | Jul 1992 | A |
5133742 | Pinchuk | Jul 1992 | A |
5134070 | Casnig | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5145727 | Potts et al. | Sep 1992 | A |
5149576 | Potts et al. | Sep 1992 | A |
5151231 | Lambert et al. | Sep 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5171305 | Schickling et al. | Dec 1992 | A |
5173158 | Schmukler | Dec 1992 | A |
5178612 | Fenton, Jr. | Jan 1993 | A |
5180365 | Ensminger et al. | Jan 1993 | A |
5193537 | Freeman | Mar 1993 | A |
5203771 | Melker et al. | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5213574 | Tucker | May 1993 | A |
D337637 | Tucker | Jul 1993 | S |
5229431 | Pinchuk | Jul 1993 | A |
5236417 | Wallis | Aug 1993 | A |
5240675 | Wilk et al. | Aug 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5242995 | Kim et al. | Sep 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5250038 | Melker et al. | Oct 1993 | A |
5260020 | Wilk et al. | Nov 1993 | A |
5263930 | Ensminger | Nov 1993 | A |
5273525 | Hofmann | Dec 1993 | A |
5281199 | Ensminger et al. | Jan 1994 | A |
5281205 | McPherson | Jan 1994 | A |
5283194 | Schmukler | Feb 1994 | A |
5300048 | Drewes, Jr. et al. | Apr 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5328451 | Davis et al. | Jul 1994 | A |
5330449 | Prichard et al. | Jul 1994 | A |
5334171 | Kaldany | Aug 1994 | A |
5350360 | Ensminger et al. | Sep 1994 | A |
5352204 | Ensminger | Oct 1994 | A |
5356381 | Ensminger et al. | Oct 1994 | A |
5370624 | Edwards et al. | Dec 1994 | A |
5372582 | Skrabal et al. | Dec 1994 | A |
5373855 | Skrabal et al. | Dec 1994 | A |
5387192 | Glantz et al. | Feb 1995 | A |
5389069 | Weaver | Feb 1995 | A |
5395525 | Takano et al. | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5403291 | Abrahamson | Apr 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405340 | Fageol et al. | Apr 1995 | A |
5417656 | Ensminger et al. | May 1995 | A |
5421814 | Geary | Jun 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5425752 | Vu'Nguyen | Jun 1995 | A |
5439440 | Hofmann | Aug 1995 | A |
5445608 | Chen et al. | Aug 1995 | A |
5458582 | Nakao | Oct 1995 | A |
5458625 | Kendall | Oct 1995 | A |
5476451 | Ensminger et al. | Dec 1995 | A |
5486570 | St. Clair | Jan 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5514127 | Shanks | May 1996 | A |
5520632 | Leveen et al. | May 1996 | A |
5520643 | Ensminger et al. | May 1996 | A |
5527277 | Ensminger et al. | Jun 1996 | A |
5527278 | Ensminger et al. | Jun 1996 | A |
5527307 | Srisathapat et al. | Jun 1996 | A |
5531684 | Ensminger et al. | Jul 1996 | A |
5533999 | Hood et al. | Jul 1996 | A |
5536240 | Edwards et al. | Jul 1996 | A |
5542200 | Matsuoka | Aug 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5542937 | Chee et al. | Aug 1996 | A |
5543200 | Hargis et al. | Aug 1996 | A |
5549576 | Patterson et al. | Aug 1996 | A |
5554117 | Ensminger et al. | Sep 1996 | A |
5556381 | Ensminger et al. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5571152 | Chen et al. | Nov 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5575811 | Reid et al. | Nov 1996 | A |
5589563 | Ward et al. | Dec 1996 | A |
5607393 | Ensminger et al. | Mar 1997 | A |
5613945 | Cai et al. | Mar 1997 | A |
5613974 | Andreas et al. | Mar 1997 | A |
5614136 | Pepin et al. | Mar 1997 | A |
5626146 | Barber et al. | May 1997 | A |
5634899 | Shapland et al. | Jun 1997 | A |
5637877 | Sinofsky | Jun 1997 | A |
5643197 | Brucker et al. | Jul 1997 | A |
5647859 | Lampropoulos et al. | Jul 1997 | A |
RE35601 | Eckenhoff | Sep 1997 | E |
5662616 | Bousquet | Sep 1997 | A |
5662913 | Capelli | Sep 1997 | A |
5674267 | Mir et al. | Oct 1997 | A |
5676656 | Brimhall | Oct 1997 | A |
5681289 | Wilcox et al. | Oct 1997 | A |
5695482 | Kaldany | Dec 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5702359 | Hofmann et al. | Dec 1997 | A |
5702363 | Flaherty | Dec 1997 | A |
5702754 | Zhong | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5713844 | Peyman | Feb 1998 | A |
5720921 | Meserol | Feb 1998 | A |
5723718 | Berens | Mar 1998 | A |
5725510 | Hartmann et al. | Mar 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5776096 | Fields | Jul 1998 | A |
5778894 | Dorogi et al. | Jul 1998 | A |
5779897 | Kalthod et al. | Jul 1998 | A |
5782882 | Lerman et al. | Jul 1998 | A |
5792104 | Speckman et al. | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5795326 | Siman | Aug 1998 | A |
5797886 | Roth et al. | Aug 1998 | A |
5800378 | Edwards et al. | Sep 1998 | A |
5800414 | Cazal | Sep 1998 | A |
5810762 | Hofmann | Sep 1998 | A |
5810776 | Bacich et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5817072 | Lampropoulos et al. | Oct 1998 | A |
5830172 | Leveen et al. | Nov 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5830526 | Wilson et al. | Nov 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5836905 | Lemelson et al. | Nov 1998 | A |
5836935 | Ashton et al. | Nov 1998 | A |
5840063 | Flaherty | Nov 1998 | A |
5843026 | Edwards et al. | Dec 1998 | A |
5855203 | Matter | Jan 1999 | A |
5873849 | Bernard | Feb 1999 | A |
5876366 | Dykstra et al. | Mar 1999 | A |
5879322 | Lattin et al. | Mar 1999 | A |
5879333 | Smith | Mar 1999 | A |
5879499 | Corvi | Mar 1999 | A |
5882341 | Bousquet | Mar 1999 | A |
5902279 | Powles | May 1999 | A |
5906596 | Tallarida | May 1999 | A |
5908701 | Jennings et al. | Jun 1999 | A |
5919142 | Boone et al. | Jul 1999 | A |
5928174 | Gibbins | Jul 1999 | A |
5929201 | Gibbons et al. | Jul 1999 | A |
5944688 | Lois | Aug 1999 | A |
5947889 | Hehrlein | Sep 1999 | A |
5951512 | Dalton | Sep 1999 | A |
5954691 | Prosl | Sep 1999 | A |
5954966 | Matsuura et al. | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
5983131 | Weaver et al. | Nov 1999 | A |
5989216 | Johnson et al. | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5999847 | Elstrom | Dec 1999 | A |
6001079 | Pourchez | Dec 1999 | A |
6001080 | Kuracina et al. | Dec 1999 | A |
6009347 | Hofmann | Dec 1999 | A |
6010613 | Walters et al. | Jan 2000 | A |
6016452 | Kasevich | Jan 2000 | A |
6030411 | Lawandy | Feb 2000 | A |
6033393 | Balbierz et al. | Mar 2000 | A |
6039712 | Fogarty | Mar 2000 | A |
6041252 | Walker et al. | Mar 2000 | A |
6055453 | Hofmann et al. | Apr 2000 | A |
6068650 | Hofmann et al. | May 2000 | A |
6085115 | Weaver et al. | Jul 2000 | A |
6086555 | Eliasen et al. | Jul 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6093180 | Elsberry | Jul 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6102884 | Squitieri | Aug 2000 | A |
6102885 | Bass | Aug 2000 | A |
6106521 | Blewett et al. | Aug 2000 | A |
6109270 | Mah et al. | Aug 2000 | A |
6111049 | Sendijarevic et al. | Aug 2000 | A |
6120492 | Finch et al. | Sep 2000 | A |
6122599 | Mehta | Sep 2000 | A |
6127485 | Klun et al. | Oct 2000 | A |
6127507 | Santerre | Oct 2000 | A |
6132416 | Broselow | Oct 2000 | A |
6132419 | Hofmann | Oct 2000 | A |
6159163 | Strauss et al. | Dec 2000 | A |
6177522 | Brady et al. | Jan 2001 | B1 |
6197845 | Janssen et al. | Mar 2001 | B1 |
6197846 | Combe et al. | Mar 2001 | B1 |
6200338 | Solomon et al. | Mar 2001 | B1 |
6208893 | Hofmann | Mar 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6212433 | Behl | Apr 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6213995 | Steen et al. | Apr 2001 | B1 |
6216034 | Hofmann et al. | Apr 2001 | B1 |
6217566 | Ju et al. | Apr 2001 | B1 |
6219577 | Brown, III et al. | Apr 2001 | B1 |
6227200 | Crump et al. | May 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6241702 | Lundquist et al. | Jun 2001 | B1 |
6245039 | Brugger et al. | Jun 2001 | B1 |
6254645 | Kellis, Jr. et al. | Jul 2001 | B1 |
6261831 | Agee | Jul 2001 | B1 |
6273404 | Holman et al. | Aug 2001 | B1 |
6278895 | Bernard | Aug 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6300108 | Rubinsky et al. | Oct 2001 | B1 |
6326177 | Schoenbach et al. | Dec 2001 | B1 |
6347247 | Dev et al. | Feb 2002 | B1 |
6349233 | Adams | Feb 2002 | B1 |
6351674 | Silverstone | Feb 2002 | B2 |
6353057 | He et al. | Mar 2002 | B1 |
6355020 | Bousquet | Mar 2002 | B1 |
6355858 | Gibbins | Mar 2002 | B1 |
6368658 | Schwarz et al. | Apr 2002 | B1 |
6375637 | Campbell et al. | Apr 2002 | B1 |
6387105 | Gifford, III et al. | May 2002 | B1 |
6387671 | Rubinsky et al. | May 2002 | B1 |
6403348 | Rubinsky et al. | Jun 2002 | B1 |
6409700 | Siegel, Jr. et al. | Jun 2002 | B1 |
6419643 | Shimada et al. | Jul 2002 | B1 |
6419674 | Bowser et al. | Jul 2002 | B1 |
6428513 | Abrahamson | Aug 2002 | B1 |
6442415 | Bis et al. | Aug 2002 | B1 |
6446671 | Armenia et al. | Sep 2002 | B2 |
6448364 | Clatty et al. | Sep 2002 | B1 |
6461568 | Eckhardt | Oct 2002 | B1 |
6461569 | Boudreaux | Oct 2002 | B1 |
6470211 | Ideker et al. | Oct 2002 | B1 |
6482619 | Rubinsky et al. | Nov 2002 | B1 |
6493592 | Leonard et al. | Dec 2002 | B1 |
6500173 | Underwood et al. | Dec 2002 | B2 |
6517520 | Chang et al. | Feb 2003 | B2 |
6526320 | Mitchell | Feb 2003 | B2 |
6530951 | Bates et al. | Mar 2003 | B1 |
6545097 | Pinchuk et al. | Apr 2003 | B2 |
6551346 | Crossley | Apr 2003 | B2 |
6562604 | Rubinsky et al. | May 2003 | B2 |
6575959 | Sarge et al. | Jun 2003 | B1 |
6592544 | Mooney et al. | Jul 2003 | B1 |
6595966 | Davey et al. | Jul 2003 | B2 |
6605075 | Burdulis | Aug 2003 | B1 |
6605751 | Gibbins et al. | Aug 2003 | B1 |
6607529 | Jones et al. | Aug 2003 | B1 |
6610046 | Usami et al. | Aug 2003 | B1 |
6611706 | Avrahami et al. | Aug 2003 | B2 |
6613211 | McCormick et al. | Sep 2003 | B1 |
6627421 | Unger et al. | Sep 2003 | B1 |
6629950 | Levin | Oct 2003 | B1 |
6630086 | Goral et al. | Oct 2003 | B1 |
6638252 | Moulton et al. | Oct 2003 | B2 |
6645230 | Whitehurst | Nov 2003 | B2 |
6653091 | Dunn et al. | Nov 2003 | B1 |
6669691 | Taimisto | Dec 2003 | B1 |
6692493 | McGovern et al. | Feb 2004 | B2 |
6693093 | Chowdhary et al. | Feb 2004 | B2 |
6697669 | Dev et al. | Feb 2004 | B2 |
6697670 | Chomenky et al. | Feb 2004 | B2 |
6702808 | Kreindel | Mar 2004 | B1 |
6719727 | Brimhall et al. | Apr 2004 | B2 |
6730113 | Eckhardt et al. | May 2004 | B2 |
6777466 | Eckstein et al. | Aug 2004 | B2 |
6795728 | Chornenky et al. | Sep 2004 | B2 |
6801804 | Miller et al. | Oct 2004 | B2 |
6819951 | Patel et al. | Nov 2004 | B2 |
6827710 | Mooney et al. | Dec 2004 | B1 |
6865416 | Dev et al. | Mar 2005 | B2 |
6892099 | Jaafar et al. | May 2005 | B2 |
6897349 | Gibbins et al. | May 2005 | B2 |
6912417 | Bernard et al. | Jun 2005 | B1 |
6927049 | Rubinsky et al. | Aug 2005 | B2 |
6929631 | Brugger et al. | Aug 2005 | B1 |
6938668 | Whicher et al. | Sep 2005 | B2 |
6939357 | Navarro et al. | Sep 2005 | B2 |
6962580 | Adams et al. | Nov 2005 | B2 |
6962587 | Johnson et al. | Nov 2005 | B2 |
6969381 | Voorhees | Nov 2005 | B2 |
6972014 | Eum et al. | Dec 2005 | B2 |
6994706 | Chornenky et al. | Feb 2006 | B2 |
6997914 | Smith et al. | Feb 2006 | B2 |
7053063 | Rubinsky et al. | May 2006 | B2 |
7063698 | Whayne et al. | Jun 2006 | B2 |
7070591 | Adams et al. | Jul 2006 | B2 |
7130697 | Chornenky et al. | Oct 2006 | B2 |
7179849 | Terry | Feb 2007 | B2 |
7186239 | Woehr | Mar 2007 | B2 |
7211083 | Chornenky et al. | May 2007 | B2 |
7261708 | Raulerson | Aug 2007 | B2 |
7264858 | Belliveau et al. | Sep 2007 | B2 |
7267676 | Chornenky et al. | Sep 2007 | B2 |
7351233 | Parks | Apr 2008 | B2 |
7410602 | Davey et al. | Aug 2008 | B2 |
7731700 | Schytte | Jun 2010 | B1 |
7785302 | Powers | Aug 2010 | B2 |
7947022 | Amin et al. | May 2011 | B2 |
7959615 | Stats et al. | Jun 2011 | B2 |
8021324 | Bizup et al. | Sep 2011 | B2 |
8025639 | Powers et al. | Sep 2011 | B2 |
8029482 | Maniar et al. | Oct 2011 | B2 |
8071683 | Mullick et al. | Dec 2011 | B2 |
8177762 | Beasley et al. | May 2012 | B2 |
8178620 | Mullick et al. | May 2012 | B2 |
8187234 | Weaver et al. | May 2012 | B2 |
8202259 | Evans et al. | Jun 2012 | B2 |
8257325 | Schweikert et al. | Sep 2012 | B2 |
8267915 | Daly et al. | Sep 2012 | B2 |
8317773 | Appling et al. | Nov 2012 | B2 |
8318867 | Mullick et al. | Nov 2012 | B2 |
8338537 | Mullick et al. | Dec 2012 | B2 |
D676955 | Orome | Feb 2013 | S |
8377011 | Weaver et al. | Feb 2013 | B2 |
8382723 | Powers et al. | Feb 2013 | B2 |
8382724 | Maniar et al. | Feb 2013 | B2 |
20010016717 | Haarala et al. | Aug 2001 | A1 |
20010044596 | Jaafar | Nov 2001 | A1 |
20010047195 | Crossley | Nov 2001 | A1 |
20010056266 | Tallarida et al. | Dec 2001 | A1 |
20020010491 | Schoenbach et al. | Jan 2002 | A1 |
20020055731 | Atala et al. | May 2002 | A1 |
20020077676 | Schroeppel et al. | Jun 2002 | A1 |
20020082559 | Chang et al. | Jun 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020099323 | Dev et al. | Jul 2002 | A1 |
20020138068 | Watson et al. | Sep 2002 | A1 |
20020138117 | Son | Sep 2002 | A1 |
20020165594 | Biel | Nov 2002 | A1 |
20020193831 | Smith | Dec 2002 | A1 |
20030009110 | Tu et al. | Jan 2003 | A1 |
20030017073 | Eckhardt et al. | Jan 2003 | A1 |
20030060856 | Chornenky et al. | Mar 2003 | A1 |
20030065355 | Weber | Apr 2003 | A1 |
20030088189 | Tu et al. | May 2003 | A1 |
20030109871 | Johnson et al. | Jun 2003 | A1 |
20030130711 | Pearson et al. | Jul 2003 | A1 |
20030135168 | Benchetrit | Jul 2003 | A1 |
20030170898 | Gundersen et al. | Sep 2003 | A1 |
20030194433 | Hei et al. | Oct 2003 | A1 |
20030203991 | Schottman et al. | Oct 2003 | A1 |
20030208200 | Palanker et al. | Nov 2003 | A1 |
20030220628 | Klisch et al. | Nov 2003 | A1 |
20030225360 | Eppstein et al. | Dec 2003 | A1 |
20040019371 | Jaafar et al. | Jan 2004 | A1 |
20040034398 | Eckhardt et al. | Feb 2004 | A1 |
20040059389 | Chornenky et al. | Mar 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040068241 | Fischer | Apr 2004 | A1 |
20040068251 | Chan et al. | Apr 2004 | A1 |
20040068315 | Chandrasekaran et al. | Apr 2004 | A1 |
20040073171 | Rogers et al. | Apr 2004 | A1 |
20040076582 | Dimatteo et al. | Apr 2004 | A1 |
20040116965 | Falkenberg | Jun 2004 | A1 |
20040121175 | Flexman et al. | Jun 2004 | A1 |
20040131863 | Belliveau et al. | Jul 2004 | A1 |
20040133173 | Edoga et al. | Jul 2004 | A1 |
20040146877 | Diss et al. | Jul 2004 | A1 |
20040153057 | Davison | Aug 2004 | A1 |
20040167463 | Zawacki et al. | Aug 2004 | A1 |
20040171747 | Zhong | Sep 2004 | A1 |
20040199128 | Morris et al. | Oct 2004 | A1 |
20040204691 | Yashiro et al. | Oct 2004 | A1 |
20040243103 | King et al. | Dec 2004 | A1 |
20040243107 | Macoviak et al. | Dec 2004 | A1 |
20040267189 | Mayor et al. | Dec 2004 | A1 |
20050010275 | Sahatjian et al. | Jan 2005 | A1 |
20050013988 | Fu et al. | Jan 2005 | A1 |
20050033237 | Fentress et al. | Feb 2005 | A1 |
20050043726 | McHale et al. | Feb 2005 | A1 |
20050049541 | Behar et al. | Mar 2005 | A1 |
20050059958 | Lessard et al. | Mar 2005 | A1 |
20050104255 | Mejlhede et al. | May 2005 | A1 |
20050119724 | Phaneuf et al. | Jun 2005 | A1 |
20050124980 | Sanders | Jun 2005 | A1 |
20050131356 | Ash et al. | Jun 2005 | A1 |
20050137580 | Raulerson et al. | Jun 2005 | A1 |
20050143817 | Hunter et al. | Jun 2005 | A1 |
20050165393 | Eppstein | Jul 2005 | A1 |
20050171490 | Weaver et al. | Aug 2005 | A1 |
20050171510 | DiCarlo et al. | Aug 2005 | A1 |
20050171523 | Rubinsky et al. | Aug 2005 | A1 |
20050171574 | Rubinsky et al. | Aug 2005 | A1 |
20050176893 | Rana et al. | Aug 2005 | A1 |
20050182352 | DiMatteo et al. | Aug 2005 | A1 |
20050182462 | Chornenky et al. | Aug 2005 | A1 |
20050192546 | Griego et al. | Sep 2005 | A1 |
20050197619 | Rule et al. | Sep 2005 | A1 |
20050216074 | Sahatjian et al. | Sep 2005 | A1 |
20050240080 | Diekmann et al. | Oct 2005 | A1 |
20050256461 | DiFiore et al. | Nov 2005 | A1 |
20050261636 | Rome et al. | Nov 2005 | A1 |
20050261672 | Deem et al. | Nov 2005 | A1 |
20050288730 | Deem et al. | Dec 2005 | A1 |
20060004325 | Hamatake et al. | Jan 2006 | A1 |
20060015086 | Rasmussen et al. | Jan 2006 | A1 |
20060015147 | Persson et al. | Jan 2006 | A1 |
20060025760 | Podhajsky | Feb 2006 | A1 |
20060052757 | Fischer et al. | Mar 2006 | A1 |
20060064159 | Porter et al. | Mar 2006 | A1 |
20060079883 | Elmouelhi et al. | Apr 2006 | A1 |
20060100592 | Eliasen | May 2006 | A1 |
20060121610 | Rubinsky et al. | Jun 2006 | A1 |
20060178648 | Barron et al. | Aug 2006 | A1 |
20060189922 | Amarasinghe et al. | Aug 2006 | A1 |
20060212078 | Demarais et al. | Sep 2006 | A1 |
20060217703 | Chornenky et al. | Sep 2006 | A1 |
20060247584 | Sheetz et al. | Nov 2006 | A1 |
20060264752 | Rubinsky et al. | Nov 2006 | A1 |
20060264833 | Moulton | Nov 2006 | A1 |
20060293730 | Rubinsky et al. | Dec 2006 | A1 |
20070037891 | Esfand et al. | Feb 2007 | A1 |
20070043345 | Davalos et al. | Feb 2007 | A1 |
20070060989 | Deem et al. | Mar 2007 | A1 |
20070078385 | Accisano et al. | Apr 2007 | A1 |
20070078391 | Wortley et al. | Apr 2007 | A1 |
20070118069 | Persson et al. | May 2007 | A1 |
20070161940 | Blanchard et al. | Jul 2007 | A1 |
20070167925 | Jacqmein | Jul 2007 | A1 |
20070191771 | Moyer | Aug 2007 | A1 |
20070219497 | Johnson et al. | Sep 2007 | A1 |
20070239099 | Goldfarb et al. | Oct 2007 | A1 |
20070255237 | Lobl et al. | Nov 2007 | A1 |
20070260221 | Chesnin | Nov 2007 | A1 |
20070270754 | Soderholm et al. | Nov 2007 | A1 |
20070287967 | Hekmat et al. | Dec 2007 | A1 |
20080052786 | Lin et al. | Feb 2008 | A1 |
20080108975 | Appling et al. | May 2008 | A1 |
20080154186 | Appling et al. | Jun 2008 | A1 |
20080228253 | Mullick et al. | Sep 2008 | A1 |
20080234659 | Cheng et al. | Sep 2008 | A1 |
20080294111 | Tal et al. | Nov 2008 | A1 |
20080306465 | Bailey et al. | Dec 2008 | A1 |
20090036768 | Seehusen et al. | Feb 2009 | A1 |
20090118683 | Hanson | May 2009 | A1 |
20090171319 | Guo et al. | Jul 2009 | A1 |
20090171436 | Casanova et al. | Jul 2009 | A1 |
20090204074 | Powers et al. | Aug 2009 | A1 |
20090211968 | Ho et al. | Aug 2009 | A1 |
20090216216 | Powers et al. | Aug 2009 | A1 |
20090306606 | Lancette et al. | Dec 2009 | A1 |
20090326515 | Kagan | Dec 2009 | A1 |
20100049147 | Tanikawa et al. | Feb 2010 | A1 |
20100106094 | Fisher et al. | Apr 2010 | A1 |
20100191165 | Appling et al. | Jul 2010 | A1 |
20110009799 | Mullick et al. | Jan 2011 | A1 |
20110071500 | Lareau | Mar 2011 | A1 |
20110098662 | Zinn | Apr 2011 | A1 |
20110160673 | Magalich et al. | Jun 2011 | A1 |
20110184353 | DeMaria | Jul 2011 | A1 |
20110207893 | Mullick et al. | Aug 2011 | A1 |
20110264058 | Linden et al. | Oct 2011 | A1 |
20120053512 | Muse | Mar 2012 | A1 |
20120095440 | Islam | Apr 2012 | A1 |
20120148774 | Mullick et al. | Jun 2012 | A1 |
20120184925 | Grant | Jul 2012 | A1 |
20120220724 | Mullick et al. | Aug 2012 | A1 |
20120232472 | Bhagchandani et al. | Sep 2012 | A1 |
20130060200 | Dalton et al. | Mar 2013 | A1 |
20130102962 | Shih | Apr 2013 | A1 |
Number | Date | Country |
---|---|---|
4000893 | Jul 1991 | DE |
0378132 | Jul 1990 | EP |
0670169 | Jul 1990 | EP |
0935482 | Aug 1999 | EP |
WO9639531 | Dec 1996 | WO |
WO9818506 | May 1998 | WO |
WO0020554 | Apr 2000 | WO |
WO0107583 | Feb 2001 | WO |
WO0107584 | Feb 2001 | WO |
WO0107585 | Feb 2001 | WO |
WO0181533 | Nov 2001 | WO |
WO0187416 | Nov 2001 | WO |
WO02102421 | Dec 2002 | WO |
WO2004037341 | May 2004 | WO |
WO2005065284 | May 2004 | WO |
Entry |
---|
Guiffant, et al, Impact of the Shape of the Implantable Ports on their Efficiency of flow (Injection and Flushing), Medical Devices: Evidence and Research 2014:7, pp. 319-324. |
Chand, et al, Use of Vascular Ports for Long-Term Apheresis in Children, J Vasc Interv Radiol 2015, 26: 1669-1672. |
Shrestha, et al, Use of a Dual Lumen Port for Automated Red Cell Exchange in Adults with Sickle Cell Disease, Journal of Clinical Apheresis, 2015. |
Sails et al., Can Peripherally Inserted Central Catheters be Used for Contrast Injection with a CT Power Injector?, JVIR vol. 13, Issue 2, Feb. 2002, Supplement S1. |
Garland et al., Measurement of Extravascular Lung Water in Hemodialysis Patients Using Blood Ultrasound Velocity and Optical Density Dilution, American Society of Artificial Internal Organs Journal, 2002, pp. 398-403. |
Teichgraber et al., Central Venous Access Catheters: Radiological Management of Complications, Cardiovascular and Interventional Radiology, Jul. 31, 2003, pp. 321-333. |
Glickman et al., Challenges of hemodialysis access for high risk patients: Impact of mesenteric vein bioprosthetic graft, The Journal of Vascular Access, 2003 pp. 73-80. |
Choi et al., Peritoneal Dialysis, Medicine, 2003, pp. 70-73. |
Scher et al., Alternative Graft Materials for Hemodialysis Access, Seminars in Vascular Surgery, vol. 17, No. 1, Mar. 2004, pp. 19-24. |
Wentling, Hemodialysis Catheters: Materials, Design and Manufacturing, Hemodialysis Vascular Access and Peritoneal Dialysis Access, vol. 142, 2004, pp. 112-127. |
Siegman-Igra et al, Diagnosis of Vascular Catheter-Related Bloodstream Infection: a Meta-Analysis, Journal of Clinical Microbiology, vol. 35, No. 4, Apr. 1997, pp. 928-936. |
Kindgen-Milles et al, Assessment of Temporary Dialysis Catheter Performance on the Basis of Flow and Pressure Measurements In Vivo and In Vitro, ASAIO Journal, 2007, pp. 351-356. |
Spector et al., Clinincal Outcome of the Tal Palindrome Chronic Hemodialysis Catheter: Single Institution Experience, Journal of Vascular Interventional Radiology, vol. 19, No. 10, 2008, pp. 1434-1438. |
Nael et al., Endovascular Management of Central Thoracic Veno-Occlusive Diseases in Hemodialysis Patients: A Single Institutional Experience in 69 Consecutive Patients, Journal of Vascular Interventional Radiology, vol. 20, No. 1, 2009, pp. 46-51. |
Saad et al., Dual-Tract Transhepatic U-shaped Hemodialysis Inferior Vena Cava Catheter: A Feasibility Study in a Swine Model, Journal of Vascular Interventional Radiology, vol. 20, No. 12, Dec. 2009, pp. 1625-1631. |
Witowski et al., Peritoneal Dialysis: A Biological Membrane with a Nonbiological Fluid, Biology of Peritoneal Membrane, 2009, pp. 27-34. |
Cavallini et al., Substituting Citrate for Lactate in Peritoneal Dialysis Fluid Improves Ultrafiltration in Rats, Peritoneal Dialysis International, vol. 29, Jan. 2009, pp. 36-43. |
Chan et al., Tunneled Dialysis Catheters: Recent Trends and Future Directions, Advances in Chronic Kidney Disease, vol. 16, No. 5, Sep. 2009, pp. 386-395. |
Olinger et al., Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and postoperative hemodialysis: A preventable complication, The Journal of Thoracic and Cardiovascular Surgery, vol. 72, No. 4, Oct. 1976, pp. 503-511. |
McCarthy, et al, The Use of a Flow Rate Injetor for Contrast-Enhanced CT, Radiology, 1984, 151:800. |
Ireland, et al, Safety and Convenience of a Mechanical Injector Pump for Conorary Angiography, Catheterization and Cardiovascular Diagnosis, 1989, 16:199-201. |
Miles, et al, Safe use of an Intravenous Power Injector for CT: Experience and Protocol, RSNA, 1990, pp. 69-70. |
Carlson, et al, Safety Considerations in the Power Injection of Contrast Media Via Central Venous Catheters During Computed Tomographic Examinations, Investigative Radiology vol. 27, 1992, pp. 337-340. |
Steinbach, et al, Breast Implants, Common Complications, and Concurrent Breast Disease, RadioGraphics 1993, 13:95-118. |
Vergara, Adverse Reactions to Contrast Media in CT: Effects of Temperature and Ionic Property, Radiology 1996, 199:363-366. |
Herts, et al, Power Injection of Contrast Material through Central Venous Catheters for CT: In Vitro Evaluation, Radiology 1996, 200:731-735. |
Kaste, et al, Safe Use of Power Injectors with Central and Peripheral Venous Access Devices for Pediatric CT, Pediatr Radiol, 1996, 36:499-501. |
Urquiola, et al, Using Lead Foil as a Radiopaque Marker for Computerized Tomography Imaging when Implant Treatment Planning, Journal of Prosthetic Dentistry vol. 77 No. 2, 1997, pp. 227-228. |
Hills, et al, Experience with 100 Consecutive Central Venous Access Arm Ports Placed by Interventional Radiologists, JVIR 1997, 8:983-989. |
Ruess, et al, In-line Pressures Generated in Small-Bore Central Venous Catheters During Power Injection of CT Contrast Media, Radiology 1997, 203:625-629. |
Blot, et al, Accuracy of Totally Implanted ports, tunnelled, single and multiple-lumen contral venous catheters for measurement of central venous pressure, Intensive Care Med, 2000, pp. 1837-1842. |
Biffi, et al, A Randomized, Prospective Trial of Central Venous Ports Connected to Standard Open-Ended or Groshong Catheters in Adult Oncology Patients, American Cancer Society, 2001, pp. 1204-1212. |
Funaki, Central Venous Access: A Primer for the Diagnostic Radiologist, AJR: 179, 2002, pp. 309-318. |
Teichgraber, et al, Central Venous Access Catheters: Radiological Management of Complications, Cardiovasc Intervent Radiol, 2003, 26:321-333. |
Costa, More Than Skin Deep: An Overview of Iodinated Contrast Media, JAVA vol. 8 No. 4, 2003, pp. 34-39. |
Scher, et al, Alternative Graft Materials for Hemodialysis Access, Seminars in Vascular Surgery, vol. 17 No. 1, 2004, pp. 19-24. |
Abstracts of the World Apheresis Association 10th Congress, Jornal of Clinical Apheresis, 2004, 18: 20-58. |
Sanelli, Safety and Feasibility of Using a Central Venous Catheter for Rapid Contrast Injection Rates, AJR 183, 2004, pp. 1829-1834. |
Swindle, et al, Vascular Access Port Usage in Large Animal Species, Contemporary Topics, 2005 vol. 44 No. 27 pp. 7-17. |
Gebauer, Contrast Media Pressure Injectoin Using a Portal Catheter System—Results of an in Vitro Study, ROFO 2005, pp. 1417-1423. |
Hou, et al, Comparisons of Outcomes and Survivals for Two Central Venous Access Port Systems, Journal of Surg Oncology, 2005, 91:61-66. |
Swerdlow, Red Cell Exchange in Sickle Cell Disease, American Society of Hematology, 2006, pp. 48-53. |
Supplement to Imaging Economics, CIN Strategies: Anticipate, Manage, Prevent, 2007, S1-S18. |
Medtronic Synchromed II & Synchromed EL Priming Bolus Reference Card, 2007. |
International Search Report PCT-US-99-03982_ISR dated Jul. 14, 1999. |
International Search Report PCT-US-08-061447_IPRP dated Sep. 16, 2008. |
International Search Report PCT-US-08-061447_ISR dated Sep. 16, 2008. |
International Search Report PCT-US-12-030110_ISR dated Jul. 11, 2012. |
International Search Report PCT-US-08-078976 WOSA dated Apr. 3, 2009. |
International Search Report PCT-US-08-078976 IPRP dated Apr. 7, 2010. |
International Search Report PCT-US-08-010520 IPRP dated Mar. 9, 2010. |
International Search Report PCT-US-03-033373 ISR dated Mar. 15, 2004. |
International Search Report PCT-US-08-010520 ISR dated Feb. 24, 2009. |
International Search Report PCT-US-08-010520 WOSA dated Feb. 24, 2009. |
Number | Date | Country | |
---|---|---|---|
20160199560 A1 | Jul 2016 | US |